Roche Holding AG Participation (0QOK)

London
Currency in CHF
Disclaimer
249.07
-0.60
(-0.24%)
Closed
Day's Range
246.30
249.90
52 wk Range
190.50
335.60
Volume
723,872
Prev. Close
249.68
Open
249.27
Day's Range
246.3-249.9
52 wk Range
190.5-335.6
Volume
723,872
Average Volume (3m)
381,762
1-Year Change
-20%
Shares Outstanding
798,651,667
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
313.40
Upside +25.81%

People Also Watch

266.00
RO
-0.60%
159.10
AIRP
-0.72%
10.815
IBE
+0.42%
32.05
ABBN
-1.29%
152.92
SCHN
-1.58%
How do you feel today about 0QOK?
Vote to see community's results!
or

Roche Holding AG Participation Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD); and strategic agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize zilebesiran. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

Employees
103613

Income Statement